Sinopharm Group Co Ltd
XMUN:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
XMUN:X2S
|
CN |
|
A
|
Analog Devices Inc
XHAM:ANL
|
US |
|
Enact Holdings Inc
F:61W
|
US |
|
S
|
SPX Corp
F:SPW
|
US |
|
Orix Corp
TSE:8591
|
JP |
|
D
|
Dakota Gold Corp
F:RR6
|
US |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
|
M
|
Mitsubishi Heavy Industries Ltd
XBER:MIH
|
JP |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
W
|
Wharf Holdings Ltd
XMUN:WHA
|
HK |
|
D
|
Dai Nippon Printing Co Ltd
DUS:DNP
|
JP |
|
D
|
Daimler Truck Holding AG
F:DTG
|
DE |
|
K
|
Kinder Morgan Inc
XMUN:2KD
|
US |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
TBS Holdings Inc
OTC:TKOBF
|
JP |
|
D
|
Dakota Gold Corp
AMEX:DC
|
US |
Wall St Price Targets
X2S Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S is 2.5178 EUR with a low forecast of 1.8742 EUR and a high forecast of 3.091 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.5178
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.5178 EUR with a low forecast of 1.8742 EUR and a high forecast of 3.091 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
